1. IndiaInfoline
  2. News
  3. PR Newswire
PR Newswire News On IndiaInfoline.com
 
 
Result Express
IIFL View
  • SPARC

    SPARC is awaiting USFDA approval on its late stage innovative drugs, Elepsia (Epilepsy drug) and Xelpros (Glaucoma drug). Both ...

    Accumulate Reco. Price: 383.95

  • Narayana Hrudaya

    Company operates an asset light model with lowest capital cost per operational bed than peers (Rs28lakh per bed in Q2FY18). We ...

    Accumulate Reco. Price: 244.60